Back to Authors

Paul, Stefan N.

Mayo Clinic

Mayo Clinic

Citations 5

Phenotypic Characterization of Patients with ADPKD with PKD1 and PKD2 Pathogenic Variants Using Advanced Imaging Biomarkers
Borghol, Abdul Hamid , Debeh, Fadi George Munairdjy , Paul, Stefan N., Alkhatib, Bassel , Nader, Nay, Gregory, Adriana , Yang, Hana , Dahl, Neera K. , Kline, Timothy L. , Dahl, Neera K , Ghanem, Ahmad , Nader, Nay, Hanna, Christian , Harris, Peter C. , Chebib, Fouad T.

Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available

10.1681/asn.2024jkdywd8g Get It

Characterization of GANAB Phenotype in Patients with ADPKD Using Advanced Imaging Biomarkers
Debeh, Fadi George Munairdjy , Rangarajan, Vineetha, Borghol, Abdul Hamid , Paul, Stefan N., Alkhatib, Bassel , Nader, Nay, Gregory, Adriana , Yang, Hana , Dahl, Neera K. , Kline, Timothy L. , Dahl, Neera K , Rangarajan, Vineetha, Ghanem, Ahmad , Nader, Nay, Hanna, Christian , Harris, Peter C. , Chebib, Fouad T.

Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available

10.1681/asn.2024xrre28mc Get It

Characterization of IFT140 Phenotype in Patients with ADPKD Using Advanced Imaging Biomarkers
Debeh, Fadi George Munairdjy , Borghol, Abdul Hamid , Paul, Stefan N., Alkhatib, Bassel , Nader, Nay, Gregory, Adriana , Yang, Hana , Dahl, Neera K. , Kline, Timothy L. , Dahl, Neera K , Ghanem, Ahmad , Nader, Nay, Hanna, Christian , Harris, Peter C. , Chebib, Fouad T.

Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available

10.1681/asn.20240vzj2pha Get It

Risk factors for post-acute sequelae of COVID-19: Survey results from a tertiary care hospital
Munipalli, Bala, Ma, Yaohua , Li, Zhuo , Logvinov, Ilana I. , Paul, Stefan N., Delaney, Troy R., Knight, Dacre , Logvinov, Ilana , Ganesh, Ravindra , Knight, Dacre R T , Dabrh, Abd Moain Abu

Journal of Investigative Medicine | July 24, 2023 | Volume: 71 | Issue: 8 | Pages: 896-906

10.1177/10815589231190560 Get It

Identifying risk factors for post-acute sequelae of COVID-19 (PASC) is important. We conducted a multicenter cross-sectional survey study to define and characterize risk factors for severe COVID-19 in adults (≥18 years) treated at our virtual COVID-19 clinic from March 1, 2020, through March 31, 2021. We assessed patient demographics, symptom types, and persistence, incidence of PASC, and COVID-19–caused hospitalizations. Surveyed patients were also asked to rate their perception of the severity of their acute COVID-19 symptoms. Continuous variables were summarized descriptively. Differences among groups categorized by acute COVID-19 symptom severity level (mild/very mild, moderate, and severe/very severe) were evaluated with the Kruskal–Wallis rank sum test for continuous measures and the Pearson χ 2 test for categorical measures. A total of 3094 adults completed the survey. More respondents with severe/very severe acute COVID-19 symptoms reported having PASC than did those with mild/very mild and moderate acute symptoms. A significantly greater proportion of respondents with PASC were women (68.4% vs 56.7%, p < 0.001), had been hospitalized (12.2% vs 4.4%, p < 0.001), reported having negative psychological COVID-19–related repercussions (39.9% vs 15.3%, p < 0.001), and required more than 1 month to resume normal activities (38.8% vs 12.9%, p < 0.001) than did those without PASC. These findings may improve our understanding of PASC and provide a framework for early recognition of and intervention for patients at higher risk for PASC. Further research is needed to understand the predictors of persistent symptoms after acute SARS-CoV-2 infection and the risk of PASC.